OpGen, Inc

OpGen, Inc

OpGen, Inc

OpGen’s Clinical Services Laboratory uses advanced molecular technologies to analyze pathogens responsible for hospital acquired infections
Founded
2002
Raised
$73.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$6,000,000
Post-IPO equity - 2016
Merck Global Health Innovation Fund
$7,230,000
Post-IPO equity - 2016
Team Size
50+
Employees
$6,000,000 Post-IPO equity
FierceBiotech

Merck invests $6M in microbial diagnostics specialist OpGen